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Fig 1. Major adverse limb event (MALE)-free survival based on antithrombotic regimen.

Results: A total of 131 patients undergoing EVAR or ABF were screened,
with 91 included. Twenty-six patients underwent EVAR (28.6%) and 65
underwent ABF (71.4%). EVAR patients were older (65.5 vs 58.4 years; P
¼ .002), with more coronary artery disease (42.3 vs 21.5%; P ¼ .04) and diabetes (46.2 vs 20%; P ¼ .001). Signiﬁcant differences were seen between
EVAR and ABF, including a shorter surgery length (212 vs 359.2 minutes;
P < .0001), less blood loss (282.8 vs 711.3 mL; P < .0001), larger minimum
aortic diameter (15.9 vs. 13.1; P ¼ .0006), and larger common iliac artery
(9.8 vs 8.0; P ¼ .005). There were fewer TASC C/D iliac lesions in the
EVAR than ABF group (15.4% vs 63.1%; P < .0001) but no differences in
TASC C/D femoropopliteal lesions. Unadjusted analysis revealed no significant differences between EVAR and ABF for 30-day mortality (0% vs
2.9%; P ¼ .5), stroke (0% vs 5.7%; P ¼ .4), or major adverse cardiac events
(18.2% vs 8.6%; P ¼ .6). Mid-term surgical outcomes over a mean follow-up
period of 24.5 months between the EVAR and ABF groups for wound
infection (10% vs 8.3%; P ¼ .9), endovascular (0% vs 16.7%; P ¼ .2), or
open reintervention (10% vs 20.8%; P ¼ .5) was similar. Kaplan-Meier estimated primary patency (Fig 1) was 96% for EVAR and 95% for ABF at
60 months (P ¼ .2), and estimated survival was 96% for EVAR and 94%
for ABF at 48 months (P ¼ .7 and P ¼ .6, respectively).
Conclusions: Equivalent outcomes were seen between AIOD treated
with EVAR or ABF in similar patient populations. Mid-term outcomes
such as reintervention and patency are similarly excellent for EVAR and
ABF, even though more complex iliac lesions were treated by ABF. We
still recommend ABF over EVAR as a primary modality of treatment in
surgically ﬁt patients with greater complexity iliac lesions.

Fig 2. Primary patency rate based on antithrombotic regimen.
Fig. Kaplan-Meier curve demonstrating primary patency, by group. P ¼
.2.
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Comparative Analysis Of Outcomes Of Endovascular
Aortic Repair And Aortobifemoral Bypass For
Aortoiliac Occlusive Disease
1

1

1

Benjamin Liu, Chase Schlesselman, Todd R. Vogel, Jonathan
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Objective: Aortoiliac occlusive disease (AIOD) has traditionally been
treated with aortobifemoral bypass (ABF). Endovascular aortic repair
(EVAR) is gaining popularity in selected patients. The objective of this
study was to report outcomes of patients undergoing ABF or EVAR for
AIOD.
Methods: Patients (2016-2021) undergoing elective ABF or EVAR with
a unibody device for AIOD were identiﬁed at an academic institution.
2
c and Kaplan-Meier analysis were used to evaluate outcomes by
group.
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Objective: The objective of this study was to determine if preoperative
vein mapping (PVM) was associated with increased use of autogenous
venous conduits in a real-world registry of lower extremity infra inguinal
bypass (IIB).
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Methods: A retrospective review of a statewide vascular surgery registry
was queried for all patients between 2012 and 2020 who underwent IIB.
We excluded trauma patients and patients with acute limb ischemia,
and previous lower extremity bypasses. Preoperative and intraoperative
variables were analyzed, and postoperative outcomes were correlated
with the use of PVM.
Results: A total of 5540 patients were included in the study. The average
age was 67 years. Sixty-nine percent of the cohort were male, and 81% were
white. PVM was performed on 2532 patients (45%). Patients who underwent PVM were more likely to be white (83% vs 79%; P < .001) and have
commercial insurance (24% vs 21%; P ¼ .001). A venous conduit was significantly more likely to be used in patients who underwent preoperative vein
mapping (69% vs 28%; P < .001). When looking at patients who underwent
IIB with a venous conduit, intraoperative blood loss was signiﬁcantly less,
and 30-day transfusion tended to be lower in patients who had PVM
(290 vs 323 mL; P ¼ .032; 30% vs 26%; P ¼ .07, respectively), although no signiﬁcant difference was seen with the length of procedure (P ¼ .44). Intraoperative angiogram/duplex ultrasonography to establish technical
adequacy was more commonly used in the PVM subgroup (39% vs 32%;
P < .001) and was more likely to be reported as normal. No signiﬁcant difference was found in terms of short-term outcomes (length of stay; neurologic, renal, or cardiac complications; 30-day patency; readmission; and
death) or for surgical site infection variables (30-day readmission for wound
infection, need to return to operating room for infection).
Conclusions: Most patients do not have PVM before their IIB. Patients
who undergo PVM are more than twice as likely to have a venous conduit
used for their bypass. In patients who underwent autogenous venous
conduit bypass, postoperative imaging to establish technical adequacy
was performed more frequently in patients who underwent PVM and
was more likely to be reported as normal. Despite no change in 30-day
or 1-year patency, PVM may be a marker for physicians who are interested
in best practices for IIB.
Author disclosures: A. Natour: Nothing to Disclose; A. D. Shepard:
Nothing to Disclose; T. Nypaver: Nothing to Disclose; R. Cuff: Nothing
to Disclose; N. J. Mouawad: Nothing to Disclose; M. Mattos: Nothing to
Disclose; P. Henke: Nothing to Disclose; L. Kabbani: Nothing to
Disclose.
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Erector Spinae Block Reduces Opioid Use After
Transaxillary First Rib Resection
Alex Marrone,1 R. James Valentine,1 James Flaherty,1 Amy B. Reed2.
1
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Objective: Recent federal initiatives mandate reductions in opioid analgesic prescribing to control postoperative pain. The severe pain associated with ﬁrst rib resection for thoracic outlet syndrome is an ideal area
of focus. The erector spinae block (ESB) is a new regional anesthesia technique used to provide analgesia for relief of acute postoperative pain. The
objective of this study is to evaluate the potential beneﬁt of ESB to
reduce opioid requirements after transaxillary ﬁrst rib resection.
Methods: Consecutive patients receiving ESB after transaxillary ﬁrst rib
resection were compared with a consecutive group of controls who

Fig. Morphine milligram equivalents (MMEs).

underwent operations without block (nESB). Blocks were placed in the
operating room by regional pain anesthesiologists after rib resection. Total inpatient, postoperative opioid use was calculated as morphine milligram equivalents (MMEs) according to Centers for Disease Control
recommendations.
Results: A total of 50 patients (24 ESB, 26 nESB) were identiﬁed between June 2020 and April 2022. Demographics, indications for transaxillary ﬁrst rib resection (arterial, venous, neurogenic, combined arterial
and venous), and side of operation (right vs left) were similar in both
groups. However, signiﬁcantly more ESB subjects presented with axillary
vein thrombosis compared with those who had nESB (10 vs 3; P ¼ .02).
The MMEs were signiﬁcantly lower in the ESB group compared with
the nESB group (21 6 33 vs 64 6 74 mg; P ¼ .01) (Fig). More ESB patientss
were discharged on the same day of surgery compared with nESB patients (5 vs 0; P ¼ .02). Although fewer ESB patients returned for emergency department visits after discharge, the difference did not reach
signiﬁcance (1 vs 5; P ¼ .19). There were no complications related to the
ESB in any subject.
Conclusions: ESBs appear to be an effective adjunct for postoperative
pain control in patients undergoing transaxillary ﬁrst rib resection for
thoracic outlet syndrome. These data demonstrate reduced inpatient
opiate needs and shortened length of stay associated with routine use
of ESB.
Author disclosures: A. Marrone: Nothing to Disclose; R. J. Valentine:
Nothing to Disclose; J. Flaherty: Nothing to Disclose; A. B. Reed: Nothing
to Disclose.
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Objective: The objective of this study was to evaluate regional variation
in carotid revascularization within the Vascular Quality Initiative, 2016 to
2021.
Methods: Nineteen geographic regions were divided into three quantiles based on the average annual volume of carotid procedures performed per region (low, 956; medium, 1533; high, 1845 cases).
Regression models that adjust for known risk factors and allow for
random effects at the center level were utilized.
Results: A total of 126,768 carotid revascularization procedures were
included in study. Most patients (w70.3%) were asymptomatic. Carotid
endarterectomy (CEA) was the most common procedure (>60%) across
all regional groups. Elective CEA, shunting, drain placement, and stump
pressure monitoring were more common practices in low vs higher-

Fig. Adjusted in-hospital and 1-year stroke/death outcomes between
transcarotid artery revascularization (TCAR) vs carotid endarterectomy
(CEA) and transfemoral carotid artery stenting (TF-CAS) and between
TFCAS and CEA across low-, medium-, and high-volume regional
groups in the Vascular Quality Initiative (VQI).
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